Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
Clinical trial NCT02341495 · TERMINATED
Trial details
- NCT number
- NCT02341495
- Sponsor
- Elizabeth Henry
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.